otc glp-1 agonists Receptor Agonists: The New Wave in Diabetes Management Is GLP-1 Safe for Weight

Injection Site Reactions: Since many GLP-1 medications are administered via injection, some users may experience redness, itching, or discomfort at the injection site

Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials

Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study

These drugs not only provide unprecedented efficacy and acceptable safety in weight reduction and glycemic control for patients with obesity and Type 2 diabetes but also hold promise in broader indications, including neurodegenerative disorders, fatty liver disease, dyslipidemia, atherosclerosis, and cardiovascular conditions

Comp Biochem Physiol B Biochem Mol Biol 121(1):4956 Mentlein R, Gallwitz B, Schmidt WE (1993) Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide- 1(736)amide, peptide histidine methionine and is responsible for their degradation in human serum

Furthermore, semaglutide is superior to other GLP-1R agonists, such as liraglutide, which uses similar pharmacological mechanisms but only has a half-life of 13 h and therefore has to be injected subcutaneously daily